T-CUPS Study Still Ongoing

T-CUPS (Tolvaptan use in Cystinuria and Urolithiasis: A Pilot Study) is looking for cystinuria patients age 12-25 to participate in a pilot study of a novel treatment to reduce stone recurrence.

This FDA-approved short-term study is being conducted at Boston Children’s Hospital. It involved daily medication for eight days, two overnight stays in our research unit, and careful monitoring. Participants will be compensated. Please help us to advance the state-of-art for cystinuria treatment! If you or someone you know might be interested in learning more about this study, please contact the research office.

Cathy Matero – Clinical Research Program Administrator
Email: Catherine.Matero@childrens.harvard.edu

Caleb Nelson, MD, MPH-Principal Investigator
Email caleb.nelson@childrens.harvard.edu